Examining product risk in context. Market withdrawal of zomepirac as a case study.
UMass Chan Affiliations
Department of Medicine, Division of Geriatric MedicineMeyers Primary Care Institute
Document Type
Journal ArticlePublication Date
1993-10-27Keywords
AnalgesiaAnalgesics
Anti-Inflammatory Agents, Non-Steroidal
Dextropropoxyphene
Drug Approval
Drug Industry
Drug Prescriptions
Drug Utilization
Family Practice
Humans
New Jersey
Physician's Practice Patterns
Product Surveillance, Postmarketing
Risk Factors
Tolmetin
Health Services Research
Medicine and Health Sciences